换一批A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.
第一作者：
Chong-Xian,Pan
第一单位：
Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Ind. 46202, USA.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);喜树碱(Camptothecin);结直肠肿瘤(Colorectal Neoplasms);环加氧酶抑制药(Cyclooxygenase Inhibitors);腹泻(Diarrhea);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);女(雌)性(Female);氟尿嘧啶(Fluorouracil);谷氨酰胺(Glutamine);人类(Humans);醛氢叶酸(Leucovorin);男(雄)性(Male);中年人(Middle Aged);吡唑类(Pyrazoles);磺胺类(Sulfonamides);治疗结果(Treatment Outcome)
DOI
10.1159/000087302
PMID
16088234
发布时间
2018-12-01
- 浏览19
Oncology
63-70页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
